Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04837547 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

Study acronym: PEACH
StatusActive, Not Recruiting
PhasePhase 1
Started2021-09-20
View on ClinicalTrials.gov ↗

Amendment history

2026-09-24
Enrollment closed, study ongoing
2026-06-29
Study Status, Contacts/Locations v23
Trial status changed: Active, Not Recruiting → Recruiting
Study sitesdetails revised at 3 of 3 sites
2026-04-27
Study Status, Eligibility v22
Eligibility criteria+173 characters
[...] se as defined Per section 8 at the time of biopsy and tumor or bone marrow must be accessible for biopsy. Tumor or bone marrow samples submitted for analysis must contain >3020% viable tumor tissue to qualify. InNote: addition, subjectsSubjects with NB disease confined to the bone marrowwho are eligible to enroll if the degree of marrow involvement is expected to behave >30%no evidence of disease after surgical removal of their tumor are still eligible for this trial if their disease would normally require adjuvant chemotherapy treatment after surgery despite NED status. Current disease state [...] [...]
2026-03-06
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v21
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 3 of 3 sites
2026-01-30
Study Status, Contacts/Locations, References v20
Study sitescontacts updated at 1 of 3 sites
Show 19 earlier versions
2026-01-06
Study Status v19
Re-verified, no change to tracked fields
2025-10-07
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v18
Trial statusActive, Not Recruiting→Recruiting
Primary completion date2025-09→2027-09
Completion date2030-09→2032-09
Study sitesdetails revised at 3 of 3 sites
2025-09-15
Study Status v17
Re-verified, no change to tracked fields
2025-07-07
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v16
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 3 of 3 sites
2025-02-27
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v15
Trial statusActive, Not Recruiting→Recruiting
Study sitesdetails revised at 3 of 3 sites
2025-01-29
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v14
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 3 of 3 sites
2024-11-18
2 amendments v12-v13
2 re-verifications since 2024-07-18, no change to tracked fields
2024-04-09
Study Identification, Study Status, Sponsor/Collaborators v11
Lead sponsorGiselle Sholler→University of Florida
Collaborators1 entry, revised
UniversityBeat ofChildhood FloridaCancer Research Consortium
2024-04-01
Study Status, Contacts/Locations v10
Study sitesdetails revised at 2 of 3 sites
2023-09-26
Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locations v9
Study sites2→3
Lead sponsorWake Forest University Health Sciences→Giselle Sholler
2023-02-23
Study Status, Contacts/Locations v8
Study sitescontacts updated at 1 of 2 sites
2022-04-20
Study Status, Sponsor/Collaborators v7
Lead sponsorGiselle SaulnierSholler→Wake Forest University Health Sciences
2022-03-03
Study Status, Contacts/Locations v6
Study sitescontacts updated at 1 of 2 sites
2021-10-04
Study Status v5
Start dateestimated 2021-09→confirmed 2021-09-20
2021-09-08
Study Identification, Study Status, Contacts/Locations v4
Study sitesdetails revised at 1 of 2 sites
Study title+13 characters
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
2021-08-20
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2025-07→2025-09
Completion date2030-07→2030-09
Start date2021-07→2021-09
Study sitesdetails revised at 2 of 2 sites
2021-07-01
Study Status v2
Primary completion date2025-05→2025-07
Completion date2030-05→2030-07
Start date2021-05→2021-07
2021-04-30
Study Status, Sponsor/Collaborators, Contacts/Locations v1
Study sitescontacts updated at 2 of 2 sites
Collaborators+21 characters
University of Florida
2021-04-07
Original filing
University of Florida
325 trials monitored
See 23 trials at risk
Glioma
666 trials monitored
See 38 trials at risk
A Phase I open-label, multicenter study, to evaluate the safety, feasibility, and maximum tolerated dose (MTD) of treating children with newly diagnosed DIPG or recurrent neuroblastoma with molecular targeted therapy in combination with adoptive cell therapy (Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs), Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT) and Autologous G-CSF mobilized Hematopoietic Stem Cells (HSCs)).
Trial Details
NCT Number NCT04837547
Lead Sponsor University of Florida
Collaborators: Beat Childhood Cancer Research Consortium
Conditions Neuroblastoma, Diffuse Intrinsic Pontine Glioma
Enrollment 24 participants
Start Date 2021-09-20
Primary Completion 2027-09 (estimated)
Study Completion 2032-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-23